rs376493359
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001413023.1(RECQL4):c.-128C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,613,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001413023.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152192Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000604 AC: 15AN: 248314Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135096
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461148Hom.: 0 Cov.: 66 AF XY: 0.0000193 AC XY: 14AN XY: 726858
GnomAD4 genome AF: 0.000177 AC: 27AN: 152310Hom.: 0 Cov.: 34 AF XY: 0.000161 AC XY: 12AN XY: 74492
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.944C>T (p.S315L) alteration is located in exon 5 (coding exon 5) of the RECQL4 gene. This alteration results from a C to T substitution at nucleotide position 944, causing the serine (S) at amino acid position 315 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 315 of the RECQL4 protein (p.Ser315Leu). This variant is present in population databases (rs376493359, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 406955). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at